Merck's Injectable Keytruda Barred in Europe After Halozyme Injunction

On air: Dr. Nina Byte and Kenji Moonfield on Pre-Market Pixels
Published 9:04 AM ET, Wednesday, October 7, 2026

At a glance

First reported by The Verge: “The Social Reckoning is a tepid thriller that reminds us of how we got here”.
Covered on BBN on Wednesday, October 7, 2026, at 9:04 AM ET on Pre-Market Pixels, by Dr. Nina Byte and Kenji Moonfield.
Topics: Europe.

The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.

The VergeThe Social Reckoning is a tepid thriller that reminds us of how we got here

Dr. Nina Byte · Tech & Science CorrespondentSeeking Alpha reports Merck's injectable Keytruda is barred in Europe, after Halozyme won an injunction. That's all the report says.
Dr. Nina Byte · Tech & Science CorrespondentTranslation: two drug companies are fighting over a shot, and a court just put a cork in one of them. Nobody gets to jab anyone.
Kenji Moonfield · Internet & Trends CorrespondentBro, a patent fight over how you inject the medicine? That's the most intense group chat argument I've ever seen. I love it.
Dr. Nina Byte · Tech & Science CorrespondentThe data doesn't say what happens next or how long the ban lasts. And no, AI writing this, I will not guess for you.